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Research 
Nested Case-Control Study of Autoimmune Disease in an Asbestos-Exposed 
Population 
Curtis W. Noonan,1 Jean C. Pfau,1 Theodore C. Larson,2 and Michael R. Spence3 
1Center for Environmental Health Sciences, University of Montana, Missoula, Montana, USA; 2Agency for Toxic Substances and Disease 
Registry, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; 3Montana Department of Health and Human Services, 
Helena, Montana, USA 
OBJECTIVE: To explore the potential association between asbestos exposure and risk of autoimmune 
disease, we conducted a case-control study among a cohort of 7,307 current and former residents 
of Libby, Montana, a community with historical occupational and environmental exposure to 
asbestos-contaminated vermiculite. 
METHODS: Cases were defined as those who reported having one of three systemic autoimmune 
diseases (SAIDs): systemic lupus erythematosus, scleroderma, or rheumatoid arthritis (RA). 
Controls were randomly selected at a 3:1 ratio from among the remaining 6,813 screening partici- 
pants using frequency-matched age and sex groupings. 
RESULTS: The odds ratios (ORs) and 95% confidence intervals (CIs) for SAIDs among those 
> 65 years of age who had worked for the vermiculite mining company were 2.14 (95% CI, 
0.90-5.10) for all SAIDs and 3.23 (95% CI, 1.31-7.96) for RA. In this age group, exposure to 
asbestos while in the military was also an independent risk factor, resulting in a tripling in risk. 
Other measures of occupational exposure to vermiculite indicated 54% and 65% increased risk for 
SAIDs and RA, respectively. Those who had reported frequent contact with vermiculite through 
various exposure pathways also demonstrated elevated risk for SAIDs and RA. We found increasing 
risk estimates for SAIDs with increasing numbers of reported vermiculite exposure pathways 
(p < 0.001). 
CONCLUSION: These preliminary findings support the hypothesis that asbestos exposure is associ- 
ated with autoimmune disease. Refined measurements of asbestos exposure and SAID status among 
this cohort will help to further clarify the relationship between these variables. 
KEY WORDS: asbestos, autoimmune, Libby, lupus, rheumatoid arthritis, scleroderma, vermiculite. 
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An association between occupational exposures 
of inhaled particulates and autoimmunity was 
postulated as early as 1914, when Bramwell 
(1914) reported increased frequency of diffuse 
scleroderma (SSc) in stone masons. Although 
genetic factors undoubtedly exist that affect the 
development of systemic autoimmune diseases 
(SAIDs) in certain individuals, the concor- 
dance of SAIDs among identical twins is only 
25-40%, suggesting that environmental fac- 
tors play a substantial role (Powell et al. 1999). 
Indeed, several environmental agents are impli- 
cated in triggering or accelerating SAIDs, 
including mercury, iodine, vinyl chloride, cer- 
tain pharmaceuticals, and crystalline silica. 
However, much more research is needed to 
determine the mechanisms and epidemiology 
linking exposures to development of SAIDs. 
There is considerable epidemiologic evidence 
supporting the hypothesis that occupational 
silica exposure is associated with a variety of 
SAIDs, including SSc, rheumatoid arthritis 
(RA), systemic lupus erythematosus (SLE), 
glomerulonephritis, and small vessel vasculitis 
(Koeger et al. 1995; Parks et al. 1999, 2002; 
Powell et al. 1999; Steenland and Goldsmith 
1995). Research regarding asbestos exposure 
and SAIDs has been much more limited. 
Asbestos-related lung disease continues to 
be a serious and significant problem world- 
wide despite increasing awareness of health 
hazards of asbestos inhalation. Asbestos expo- 
sure is associated with various lung conditions, 
including fibrosis, pleural plaques, and cancer. 
Although the exact mechanisms leading to the 
progression of these conditions have not been 
fully explained, there is evidence that some of 
the lung abnormalities een with both asbestos 
and silica exposures are immunologically 
mediated (Hamilton et al. 1996; Holian et al. 
1997; Perkins et al. 1993). Nevertheless, it is 
unclear how these innate immune responses 
might translate to specific humoral responses. 
Increased serum immunoglobulins (Ig), posi- 
tive antinuclear antibody (ANA) tests, and 
immune complexes have been reported in 
small cohorts of individuals exposed to 
asbestos (Lange 1980; Nigam et al. 1993; 
Pfau et al. 2005; Zerva et al. 1989), but no 
comprehensive study has been undertaken to 
assess the association between asbestos expo- 
sure and autoimmune disease. 
Our major objective, therefore, is to estab- 
lish whether such an association exists, and the 
community of Libby, Montana, provides a 
unique opportunity to investigate this ques- 
tion. Individuals in this population experi- 
enced significant exposures that occurred as a 
result of asbestos-contaminated vermiculite 
mining near the community. From the early 
1920s to 1990, the world's largest vermiculite 
deposits, located near Libby, were mined and 
processed. Vermiculite is a silicate mineral 
with unique properties and numerous com- 
mercial applications (Lockey 1984). The 
fibrous minerals contaminating Libby vermi- 
culite have been characterized as both regu- 
lated asbestos fibers (e.g., tremolite and other 
amphibole forms) and unregulated fibers (e.g., 
winchite and richterite) (Meeker et al. 2003). 
The various mining, transportation, and pro- 
cessing activities as well as the personal and 
commercial use of vermiculite in the commu- 
nity have led to widespread environmental 
exposures in the Libby area with this asbestos- 
contaminated vermiculite. Potential asbestos 
exposures in this community have been docu- 
mented not only in the miners but also in their 
family members as well as anyone who used 
the vermiculite or played near the mine tailings 
(Dixon et al. 1985). A mortality study in this 
community found more than 40-fold increases 
in standardized mortality ratios for asbestosis, 
and elevated mortality also was observed for 
malignant neoplasm of respiratory and 
intrathoracic organs (Horton et al., in press). 
Recently, the Agency for Toxic Substances 
and Disease Registry (ATSDR) conducted an 
extensive screening program of > 7,300 indi- 
viduals from this community (Peipins et al. 
2003). The initial results of this screening 
program identified various routes of exposure 
in the community and how those routes of 
exposure were associated with abnormalities 
on chest radiographs (Peipins et al. 2003). In 
addition, when the ATSDR performed its 
screening in Libby during 2000-2001, 494 
(6.7%) participants indicated that they had 
been diagnosed with SLE, SSc, or RA 
(Noonan et al. 2005). By comparison, a 
prevalence of < 1% for these three conditions 
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combined would be expected based on pooled 
estimates from 43 prevalence studies 
(acobson et al. 1997). In the present study, 
we take these data a step further by exploring 
the association of these systemic autoimmune 
conditions with various parameters of asbestos 
and/or vermiculite exposure using a nested 
case-control approach. 
Materials and Methods 
All human subjects provided informed con- 
sent for this study under a protocol approved 
by the institutional review board for the 
Centers for Disease Control and Prevention. 
The details of the ATSDR screening program 
are described elsewhere (Peipins et al. 2003). 
Briefly, individuals were eligible for the screen- 
ing program if they had resided, worked, 
attended school, or participated in other activ- 
ities in the Libby area for at least 6 months 
before 31 December 1990. All screening par- 
ticipants who were > 18 years of age and not 
pregnant (n = 6,668) were offered chest radio- 
graphs. Two independent B readers evaluated 
the radiographs for each subject for pleural 
and parenchymal abnormalities. If these two 
readers disagreed regarding the presence of 
pneumoconiosis for a subject, a third reader 
was used to adjudicate the difference. 
Participants were classified as "positive" for 
pleural or parenchymal abnormalities if at least 
two of three B readers observed this type of 
abnormality on chest radiographs. Participants 
also received spirometry testing and were con- 
sidered to have abnormal findings if they had 
a forced vital capacity (FVC) < 80% predicted 
and a ratio of 1 sec forced expiratory volume 
(FEV1) to FVC that is > 70% predicted. Data 
on exposure to asbestos-contaminated vermi- 
culite were based on occupational, residential, 
and recreational histories collected during in- 
person interviews. Demographic variables and 
data on other potential covariates were also 
collected by in-person interview. 
This study was conducted in two phases. 
The initial characterization of cases (n = 494) 
with SAIDs were those participants who, dur- 
ing the 2000-2001 ATSDR screening pro- 
gram, responded affirmatively to the question 
"Have you ever had rheumatoid arthritis, scle- 
roderma, or lupus?" Potential controls were 
those screening participants who answered 
negatively to this question. Controls were ran- 
domly selected from within strata of sex and 
10-year age groups at a 3:1 control-to-case 
ratio (n = 1,482) (Figure 1). 
The initial screening question on SAIDs 
was collected only to identify screening partici- 
pants with health conditions that could have an 
impact on pulmonary function or fibrosis. The 
Initial 
analysis 
Responses from 
mailed survey 
(n = 208; 42%) 
Secondary 
analysis 
Figure 1. Case and control selection from initial screening population. DPHHS, Montana Department of 
Public Health and Human Services. Lupus refers to SLE. 
second phase of this study involved a mailed 
questionnaire to confirm the original self- 
reports of SAIDs and to identify which of the 
three conditions the potential cases were report- 
ing. The follow-up survey was mailed to all 494 
potential SAID cases for whom current 
addresses were available. The follow-up survey 
queried potential cases on whether or not they 
still considered themselves to have one of the 
three indicated SAIDs, which SAID(s) they 
had, whether or not their SAIDs were diag- 
nosed by a physician, and whether or not they 
were taking medication or other treatment for 
their condition. For those reporting RA, addi- 
tional questions were asked to confirm the type 
of arthritis on which they were reporting (i.e., 
RA, osteoarthritis, or general arthritis). This fol- 
low-up survey was approved by the University 
of Montana investigational review board. 
Analyses were conducted using uncondi- 
tional logistic regression using SAS (version 9; 
SAS Institute Inc., Cary, NC). The presence or 
absence of SAIDs or a specific autoimmune 
disease in the postmailing analysis was used as 
the dependent variable. The various pathways 
of exposure to vermiculite and/or asbestos were 
considered as the main independent variables 
of interest. Test for trend with increasing num- 
bers of exposure pathways was assessed using 
the Cochran-Armitage test. Potential con- 
founders included indications of restrictive 
spirometry and the presence of pleural or 
parenchymal abnormalities. These pulmonary 
features were the main outcomes of the 
ATSDR screening program and could be inde- 
pendently associated with both asbestos expo- 
sure and biomarkers of autoimmunity (Pfau 
et al. 2005). For the final unconditional logis- 
tic regression models, all vermiculite/asbestos 
exposure pathways and other potential risk fac- 
tors were considered. Criteria for inclusion in 
the final model included statistical significance 
of the explanatory variable (p < 0.10), the pres- 
ence of a confounding effect on other variables, 
and the fit of the model. 
Results 
The distribution of SAID subjects for selected 
characteristics are presented in Table 1. 
Among the 494 subjects responding positively 
to the original SAID screening question, 
287 (58%) were women. More than 75% of 
SAID subjects lived in Libby for at least 
15 years. Follow-up mailed questionnaires 
were sent to all 494 subjects who were classi- 
fied as having SAIDs in the initial analysis. Of 
these, 208 (43%) participants responded. 
Among those responding, 161 participants 
confirmed that they had a physician-diagnosed 
SAID. The proportional distribution of those 
reporting physician-diagnosed SAIDs was simi- 
lar to the original 494 who reported SAIDs 
with regard to sex, age, smoking history, and 
years lived in Libby (Table 1). Among those 
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reporting physician-diagnosed SAIDs, 129 par- 
ticipants indicated that they had physician- 
diagnosed RA, 70% of whom took medication 
for RA. Thirty participants indicated that they 
had physician-diagnosed SLE, 63% of whom 
took medication for SLE. Another four partici- 
pants indicated that they had SSc, and two of 
those took medication for SSc. 
Considering the initial case group 
(n = 494), the distribution of years of resi- 
dence was not different for cases and controls 
(X2 = 0.57, p < 0.90). Current and former 
smokers were more common among SAID 
subjects [odds ratio (OR) = 1.72; 95% confi- 
dence interval (CI), 1.22-2.44]. SAIDs also 
were associated with parenchymal abnormali- 
ties and with restrictive spirometry but not 
strongly with pleural abnormalities (Table 2). 
These associations remained consistent when 
evaluating those reporting physician-diagnosed 
SAIDs (n = 161) (Table 2). Both restrictive 
spirometry and parenchymal abnormalities as 
well as current or former smoking were 
included in the unconditional logistic regres- 
sion models for vermiculite/asbestos exposure 
and risk of SAIDs. 
The adjusted ORs for various potential 
exposure pathways to vermiculite and asbestos 
and risk of SAIDs are presented in Table 3. 
Previous occupation with the mining com- 
pany yielded no overall increased risk for 
SAIDs (OR = 1.03; 95% CI, 0.69-1.58). 
However, we observed elevated ORs for pre- 
vious occupation with the mining company 
among those > 65 years of age at the time of 
the screening, particularly for RA. Among 
other occupational vermiculite exposures, 
"dust or vermiculite exposure at jobs other 
than W.R. Grace/Zonolite" was the most 
consistently associated with reporting of any 
SAID or RA specifically. Among other occu- 
pations with potential exposure to asbestos, 
only those reporting asbestos exposure in the 
military were at increased risk for SAIDs and 
RA, yielding ORs of 1.70 and 2.11, respec- 
tively. Several reported activities or experi- 
ences were associated with increased risk of 
any SAID or RA specifically. Considering all 
exposure pathways collectively, increasing 
opportunities for vermiculite and/or asbestos 
exposure yielded increasing risk estimates for 
SAIDs and RA (Table 4). Although the num- 
ber of SLE cases was too small (n = 30) to 
evaluate for trend as in Table 4, we did 
observe an elevated risk for SLE among those 
with more than three pathways of exposure 
versus those with three or fewer pathways of 
exposure (OR = 4.45; 95% CI, 1.24-16.00). 
We did not observe sufficient numbers of SSc 
cases to evaluate this disease by asbestos expo- 
sure pathways. 
Table 5 presents final unconditional 
logistic regression models in which all expo- 
sure pathways and other potential risk factors 
were considered for their contribution to the 
risk of SAIDs and RA. Because older partici- 
pants had differing occupational risk factors, 
we constructed models stratified by age. For 
participants < 65 years of age, dust or vermi- 
culite exposure at jobs other than W.R. 
Grace/Zonolite was the only occupational 
exposure that remained in the models for both 
SAIDs and RA. For participants > 65 years of 
age, asbestos exposure in the military yielded 
substantially elevated risk estimates for both 
SAIDs and RA. For this age group, working at 
W.R. Grace/Zonolite also resulted in a 3-fold 
greater risk for RA. Elevated ORs were also 
observed for several nonoccupational expo- 
sures to vermiculite (Table 5). 
Discussion 
Although there is considerable epidemiologic 
evidence supporting the hypothesis that occu- 
pational silica exposure is associated with a 
variety of SAIDs, research regarding asbestos 
Table 1. Distribution [  (%)] of selected characteristics for participants reporting any SAID, RA, or SLE. 
Characteristic SAIDsa (n = 494) SAIDsb (n = 161) RA (n = 129) SLE (n = 30) 
Sex 
Male 207 (41.9) 69 (42.9) 61 (47.3) 2 (6.7) 
Female 287 (58.1) 92 (57.1) 68 (52.7) 28 (93.3) 
Age (years)c 
17-44 69 (14.0) 18(11.2) 15 (11.6) 5(16.7) 
45-64 258 (52.2) 97 (60.3) 80 (62.0) 21(70.0) 
>65 167 (33.8) 46 (28.6) 34 (26.4) 4(13.3) 
Smoking history 
Never 163 (33.1) 51(31.9) 35 (27.3) 11(36.7) 
Ex-smoker 214(43.4) 78 (48.8) 64 (50.0) 14(46.7) 
Current 116(23.5) 31(19.4) 29 (22.7) 5(16.7) 
Years lived in Libby 
0.5-14 118(23.9) 37 (22.9) 28 (21.7) 0 (0.0) 
15-27 133 (26.9) 41(25.5) 36(27.9) 9(30.0) 
28-39 120(24.3) 47(29.2) 39(30.2) 12(40.0) 
> 40 123 (24.9) 36 (22.4) 26 (20.2) 9 (30.0) 
"Subjects responding positively to original screening question on SAIDs. bSubjects confirming physician-diagnosed 
SAIDs in follow-up mailing. CAge as of 1 January 2000. 
Table 2. Association between SAIDs and positive findings for chest radiograph and pulmonary function. 
Medical evaluation utcome SAIDsa (n = 494) OR (95% Cl) SAIDsb (n = 161) OR (95% Cl) 
Pulmonary function test abnormalityc 90 1.76 (1.34-2.32) 37 2.23 (1.50-3.33) 
Pleural bnormalityd 134 1.15(0.91-1.45) 46 1.25(0.87-1.79) 
Parenchymal abnormalityd 27 2.54 (1.51-4.27) 9 2.62 (1.23-5.58) 
"Subjects responding positively to original screening question on SAIDs. bSubjects confirming physician-diagnosed 
SAIDs in follow-up mailing. CFVC < 80% predicted and an FEVi:FVC ratio > 70% predicted. dAt least wo of three B readers 
observed this type of abnormality on chest radiographs. 
Table 3. Adjusted ORsa (95% CIs) for vermiculite/asbestos exposure and risk of any SAID or RA specifi- 
cally, Libby, Montana. 
Exposure pathway SAIDsb (n = 494) SAIDsc (n = 161) RA (n = 129) 
Potential occupational exposure to vermiculite 
Ever work for W.R. Grace/Zonolite 
Age < 65 years 0.57 (0.29-1.11) 0.74 (0.29-1.91) 0.52 (0.16-1.70) 
Age > 65 years 1.47 (0.82-2.63) 2.14 (0.90-5.10) 3.23 (1.31-7.96) 
Contract worker for W.R. Grace/Zonolite 1.29 (0.89-1.89) 1.21 (0.67-2.20) 1.29 (0.89-1.89) 
Live with W.R. Grace/Zonolite workers 1.19 (0.93-1.53) 1.29 (0.88-1.90) 1.23 (0.80-1.90) 
Dust or vermiculite exposure at other jobs 1.33 (1.08-1.64) 1.54 (1.10-2.15) 1.65 (1.14-2.39) 
Potential occupational exposure to asbestos 
Worked mixing, cutting, or spraying asbestos 1.39 (0.76-2.54) 0.47 (0.11-2.01) 0.59 (0.14-2.53) 
Worked inshipyard/ship construction 1.27 (0.68-2.37) 1.23 (0.46-3.25) 1.80 (0.72-4.46) 
Asbestos exposure in the military 1.05 (0.62-1.79) 1.70 (0.84-3.44) 2.11 (1.04-4.30) 
Worked inconstruction-related jobsd 1.21 (0.79-1.84) 1.17 (0.60-2.27) 1.32 (0.66-2.65) 
Worked as a brake repair person 0.87 (0.49-1.55) 0.65 (0.23-1.86) 0.61 (0.19-2.02) 
Activities or experiences with potential exposure 
Frequently handled vermiculite nsulation 1.34 (0.99-1.82) 1.60 (1.02-2.52) 1.89 (1.17-3.04) 
Used vermiculite for gardening 1.31 (1.06-1.62) 1.70(1.19-2.43) 1.70 (1.15-2.53) 
Frequently recreated near Rainey Creek Road 1.50 (1.18-1.91) 1.67 (1.15-2.43) 1.78 (1.19-2.68) 
Frequently played in the vermiculite piles 1.39 (1.02-1.91) 1.85 (1.18-2.92) 2.06 (1.27-3.34) 
Frequently played at the ballfield near the plant 1.19 (0.95-1.49) 1.62 (1.14-2.30) 1.74 (1.18-2.55) 
Frequently "popped" vermiculite 1.39 (0.96-2.02) 2.11(1.27-3.52) 1.68 (0.92-3.05) 
aAdjusted for restrictive spirometry, parenchymal abnormalities, and smoking history. bSubjects responding positively to 
original screening question on SAIDs. CSubjects onfirming physician-diagnosed SAIDs in follow-up mailing. dlncludes 
carpenter, drywall finisher, insulator, roofer, plumber, lectrician, welder, and pipe fitter. 
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exposure and SAIDs has been much more 
limited. The preliminary findings presented 
here support the hypothesis that asbestos 
exposure is associated with the presence of 
autoimmune disease. We found increased risk 
for SAIDs among those reporting occupa- 
tional and environmental or recreational 
exposures to vermiculite and/or asbestos. 
Increased risk estimates were found for 
increasing numbers of reported exposure 
pathways. The risk estimates by exposure 
pathway remained elevated and in some cases 
increased after restricting the cases to those 
who responded to a follow-up survey and con- 
firmed that they had a physician-diagnosed 
SAID or RA specifically. We recognize the 
limitation of this approach of combining 
exposure pathways of unequal intensity and 
duration, but it also provides an analysis that 
parallels the previously observed findings of 
asbestos exposure and lung abnormalities in 
this population (Peipins et al. 2003). The 
multivariable analysis identified specific expo- 
sure pathways that were independently associ- 
ated with risk of SAIDs, including older 
subjects who had worked for the mining 
company. Among older participants, we also 
observed increased risk estimates for SAIDs 
and RA among those reporting exposure to 
asbestos in the military. The risk for military 
asbestos exposure was independent of the 
elevated risk for previous work at W.R. 
Grace/Zonolite and other Libby exposure 
pathways. These findings suggested that 
asbestos exposure in general rather than Libby 
vermiculite exposure in particular could be 
relevant to SAID etiology. 
These findings were consistent with a 
recent immunologic study we undertook 
among a small group of volunteers from this 
same Libby community (Pfau et al. 2005). 
The results of that study supported the 
hypothesis that increased frequency of posi- 
tive ANA would be found in the Libby group 
compared to an age- and sex-matched unex- 
posed population in Missoula, Montana. 
Among the Libby volunteers, the titers of the 
positive ANAs were positively correlated with 
the length of the individual's estimated 
asbestos exposure. Previous studies have meas- 
ured several immune parameters in popula- 
tions exposed to asbestos. Investigators in 
India demonstrated increased IgG, IgA, and 
positive ANAs in asbestos-exposed individu- 
als, compared to controls, even in the absence 
of apparent lung disease (Nigam et al. 1993). 
This finding suggested that immune altera- 
tions may precede the onset of asbestos- 
related disease. A high frequency of positive 
ANAs was also found in a Japanese group of 
asbestos plant workers (Tamura et al. 1993). 
Interestingly, a 3-year follow-up study of the 
Japanese group showed significant correlation 
of positive ANAs with progression of disease, 
leading to additional diagnoses of asbestosis in 
a previously healthy group (Tamura et al. 
1996). A study of Greek residents exposed to 
asbestos-contaminated whitewash showed a 
Table 4. Crude and adjusteda ORs (95% CIs) risk of any SAID or RA specifically, by number of vermiculite/ 
asbestos exposure pathways. 
No. of SAIDs (n= 161) RA (n= 129) 
exposure Adjusted OR Adjusted OR 
pathways Cases/controls OR (95% Cl) Cases/controls OR (95% Cl) 
0 2/34 1.00 (Referent) 1.00 (Referent) 1/34 1.00 (Referent) 1.00 (Referent) 
1 5/101 0.84 0.89 (0.16-4.83) 3/101 1.01 1.02 (0.10-10.23) 
2-3 26/345 1.28 1.36(0.31-6.04) 18/345 1.77 1.79(0.23-13.93) 
4-5 32/364 1.49 1.60(0.36-7.04) 27/364 2.52 2.51 (0.33-19.18) 
6+ 96/637 2.56 2.58(0.60-11.05) 80/637 4.27 3.98(0.53-29.66) 
Trendb p< 0.001 p< 0.001 
aAdjusted for restrictive spirometry, parenchymal abnormalities, andsmoking history. bCochran-Armitage trend t st. 
Table 5. Final model adjusted ORs (95% Cls) for vermiculite/asbestos exposure and risk of any SAID or RA 
specifically, Libby, Montana. 
SAIDs RA 
< 65 years 2 65 years < 65 years > 65 years 
Variable (n= 115) (n= 46) (n= 95) (n= 34) 
Ever work for W.R. Grace/Zonolite _a 3.03 (1.17-7.82) 
Dust or vermiculite exposure at other jobs 1.60(1.07-2.38) - 1.71 (1.10-2.66) 
Asbestos exposure in the military - 2.99 (1.04-8.59) - 3.31 (1.00-10.96) 
Used vermiculite for gardening 1.66 (1.09-2.53) - - 3.43 (1.34-8.76) 
Frequently p ayed in the vermiculite piles - -1.77 (1.03-3.04) 2.75 (0.75-10.06) 
Frequently "popped" vermiculite - 4.33 (1.59-11.80) 
Restrictive spirometry 3.23 (1.91-5.47) -3.09 (1.74-5.47) 2.02 (0.87-4.72) 
Parenchymal abnormalities - 3.29 (1.31-8.25) - 2.90 (0.95-8.87) 
Current orformer smoker - 1.82 (0.89-3.69) 1.75 (1.09-2.82) 
%2, pvalueb 1.195, 0.75 0.250, 0.62 2.349, 0.80 1.211,0.88 
"Variable did not enter the final model for the given disease/age stratum. bHosmer-Lemeshow goodness-of-fit test; small 
p-value suggests that the fitted model is not an adequate model. 
correlation of immune abnormalities particu- 
larly in individuals with pleural plaques (Zerva 
et al. 1989), whereas the Japanese study 
showed a greater effect in individuals with dif- 
fuse fibrosis but not pleural plaques. In addi- 
tion, a Polish study reported increased ANA 
frequency particularly in individuals exhibiting 
lung function deficits (Lange 1980). 
Despite some inconsistency between the 
studies cited above, all of these immunologic 
studies illustrate two important considera- 
tions. First, asbestos exposure is clearly associ- 
ated with indices of autoimmune responses. 
Second, although the details vary, the auto- 
immune responses appear to correlate with 
asbestos-related disease, suggesting a possible 
role for the autoimmune responses in the dis- 
ease process. The temporal relationship among 
asbestos exposure, autoimmune response, and 
asbestos-related diseases is uncertain and 
beyond the scope of the present study. 
Nevertheless, our findings of strong associa- 
tions between asbestos and/or vermiculite 
exposure and risk of SAIDs remained robust 
after adjusting for objectively characterized 
pulmonary conditions that could be associated 
with asbestos exposure. 
As described previously, the initial case 
group was based on those who responded 
positively to a screening question about 
autoimmune conditions. Asbestos exposure 
and SAIDs is a relatively novel avenue of 
research, so it is not expected that participants 
would overreport SAIDs because of a sus- 
pected association. For the same reason, we 
would not expect self-reported asbestos expo- 
sure to be differentially misclassified with 
respect to SAID status. As a first step toward 
improving disease characterization, we con- 
ducted a mailing to all participants who indi- 
cated having an SAID during the initial 
screening program. Of those who responded to 
the mailing, almost 23% were unable to con- 
firm that they had RA, SLE, or SSc. In general, 
when restricting the analyses to those reporting 
any physician-diagnosed SAID or RA specifi- 
cally, the risk estimates for several pathways of 
asbestos and/or vermiculite exposure were 
increased. Comparisons of risk estimates 
between the original group of suspected cases 
and those who reconfirmed diagnosis should 
be made with caution, however, because both 
sets of cases are based on self-report. 
Given the unique circumstances of com- 
munity asbestos exposure and the resulting 
screening program, it is also possible that 
there was a case ascertainment error that was 
biased with respect to exposure. Specifically, 
those with greater history of asbestos exposure 
would be more likely to have lung abnormali- 
ties or frank asbestos-related disease and 
would have received more intensive medical 
care. Better medical care could, in turn, result 
in a higher likelihood of being diagnosed with 
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other conditions uch as SAIDs. This concern 
is somewhat tempered by the fact that pleural 
abnormality, the asbestos-related condition 
that has been most strongly associated with 
asbestos exposure in this population, was not 
associated with reporting of SAIDs. 
It is also possible, but less likely, that dis- 
ease status was misclassified among controls. 
Controls were chosen from among those in the 
cohort who responded negatively to the screen- 
ing questions about autoimmune conditions, 
but we did not confirm the absence of disease 
among these selected controls. It is possible 
that some participants with SAIDs did not 
understand the screening questions and were 
inappropriately included in the pool of poten- 
tial controls. This possibility is expected to be 
of minor concern based on the low prevalence 
of these conditions in the general population 
(acobson et al. 1997). 
This study could suffer from exposure 
misclassification because these measures were 
based on self-reported responses as part of a 
large community-based screening program. 
Recall bias is a possibility, and persons with 
chronic health conditions such as SAIDs 
could overreport past exposure to vermiculite. 
In the future, we plan to improve on exposure 
characterization for this cohort, incorporating 
job exposure matrices and quantitative or 
semiquantitative assessment of other exposure 
pathways. 
In summary, these preliminary findings 
provide a unique insight into the risk for 
autoimmune disease among a population with 
historical sbestos exposures. These results war- 
rant a more comprehensive case-control study 
of this population with improved disease and 
exposure characterization and the incorporation 
of biomarkers ofgenetic susceptibility. 
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